FUJIY posts record Q2 revenue and profit, fueled by strength in Healthcare, Imaging, and Electronics, prompting a revenue forecast upgrade.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Fujifilm (FUJIY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Teiichi Goto CEO | OTC PINK Exchange | 359586302 CUSIP |
| JP Country | 72,254 Employees | 16 Jul 2019 Last Dividend | 4 Jun 1996 Last Split | - IPO Date |
FUJIFILM Holdings Corporation, established in 1934 and based in Tokyo, Japan, stands as a global developer, manufacturer, seller, and service provider of innovative solutions across Imaging, Healthcare, Materials, and Business Innovation domains. The corporation caters to a wide array of sectors by providing distinctive products and services aimed at the prevention, diagnosis, and treatment in healthcare; advancing printing and industrial materials; enhancing office environments through business innovation solutions; and enriching the imaging culture with high-quality products. FUJIFILM's commitment to innovation and sustainability is evident in its diverse portfolio, catering to the evolving needs of businesses and consumers worldwide.
Healthcare Segment:
Materials Segment:
Business Innovation Segment:
Imaging Segment: